Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi.

McGrath N, Glynn JR, Saul J, Kranzer K, Jahn A, Mwaungulu F, Ngwira MH, Mvula H, Munthali F, Mwinuka V, Mwaungulu L, Fine PE, Crampin AC.

BMC Public Health. 2010 Oct 12;10:601. doi: 10.1186/1471-2458-10-601.

2.

Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.

Brown JP, Ngwira B, Tafatatha T, Crampin AC, French N, Koole O.

AIDS Res Ther. 2016 Jul 8;13:24. doi: 10.1186/s12981-016-0110-2.

3.

Short and long term retention in antiretroviral care in health facilities in rural Malawi and Zimbabwe.

Rasschaert F, Koole O, Zachariah R, Lynen L, Manzi M, Van Damme W.

BMC Health Serv Res. 2012 Dec 5;12:444. doi: 10.1186/1472-6963-12-444.

4.

Systemic delays in the initiation of antiretroviral therapy during pregnancy do not improve outcomes of HIV-positive mothers: a cohort study.

Myer L, Zulliger R, Bekker LG, Abrams E.

BMC Pregnancy Childbirth. 2012 Sep 11;12:94. doi: 10.1186/1471-2393-12-94.

5.

Suboptimal patterns of provider initiated HIV testing and counselling, antiretroviral therapy eligibility assessment and referral in primary health clinic attendees in Blantyre, Malawi.

MacPherson P, Lalloo DG, Choko AT, Mann GH, Squire SB, Mwale D, Manda E, Makombe SD, Desmond N, Heyderman R, Corbett EL.

Trop Med Int Health. 2012 Apr;17(4):507-17. doi: 10.1111/j.1365-3156.2011.02946.x.

6.

Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi.

Tweya H, Gugsa S, Hosseinipour M, Speight C, Ng'ambi W, Bokosi M, Chikonda J, Chauma A, Khomani P, Phoso M, Mtande T, Phiri S.

Trop Med Int Health. 2014 Nov;19(11):1360-6. doi: 10.1111/tmi.12369.

7.

Determinants and consequences of failure of linkage to antiretroviral therapy at primary care level in Blantyre, Malawi: a prospective cohort study.

MacPherson P, Corbett EL, Makombe SD, van Oosterhout JJ, Manda E, Choko AT, Thindwa D, Squire SB, Mann GH, Lalloo DG.

PLoS One. 2012;7(9):e44794. doi: 10.1371/journal.pone.0044794.

8.

Very early anthropometric changes after antiretroviral therapy predict subsequent survival, in karonga, Malawi.

Maman D, Glynn JR, Crampin AC, Kranzer K, Saul J, Jahn A, Mwinuka V, Ngwira MH, Mvula H, Munthali F, McGrath N.

Open AIDS J. 2012;6:36-44. doi: 10.2174/1874613601206010036.

9.

Factors associated with timely initiation of antiretroviral therapy in two HIV clinics in Lilongwe, Malawi.

Johnson DC, Feldacker C, Tweya H, Phiri S, Hosseinipour MC.

Int J STD AIDS. 2013 Jan;24(1):42-9. doi: 10.1177/0956462412472312.

PMID:
23467293
10.

Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi.

Makombe SD, Harries AD, Yu JK, Hochgesang M, Mhango E, Weigel R, Pasulani O, Fitzgerald M, Schouten EJ, Libamba E.

Trop Doct. 2008 Jan;38(1):5-7. doi: 10.1258/td.2007.060023.

PMID:
18302849
11.

Uptake of prevention of mother-to-child-transmission using Option B+ in northern rural Malawi: a retrospective cohort study.

Price AJ, Kayange M, Zaba B, Chimbwandira FM, Jahn A, Chirwa Z, Dasgupta AN, Katundu C, Saul JL, Glynn JR, Koole O, Crampin AC.

Sex Transm Infect. 2014 Jun;90(4):309-14. doi: 10.1136/sextrans-2013-051336.

12.

Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.

Hosseinipour MC, Kumwenda JJ, Weigel R, Brown LB, Mzinganjira D, Mhango B, Eron JJ, Phiri S, van Oosterhout JJ.

HIV Med. 2010 Sep;11(8):510-8. doi: 10.1111/j.1468-1293.2010.00825.x.

13.

Retention and attrition during the preparation phase and after start of antiretroviral treatment in Thyolo, Malawi, and Kibera, Kenya: implications for programmes?

Zachariah R, Tayler-Smith K, Manzi M, Massaquoi M, Mwagomba B, van Griensven J, van Engelgem I, Arnould L, Schouten EJ, Chimbwandira FM, Harries AD.

Trans R Soc Trop Med Hyg. 2011 Aug;105(8):421-30. doi: 10.1016/j.trstmh.2011.04.014.

PMID:
21724219
14.

A national survey of teachers on antiretroviral therapy in Malawi: access, retention in therapy and survival.

Makombe SD, Jahn A, Tweya H, Chuka S, Yu JK, Hochgesang M, Aberle-Grasse J, Thambo L, Schouten EJ, Kamoto K, Harries AD.

PLoS One. 2007 Jul 18;2(7):e620.

15.

Outcomes of tuberculosis patients who start antiretroviral therapy under routine programme conditions in Malawi.

Makombe SD, Harries AD, Yu JK, Hochgesang M, Mhango E, Weigel R, Pasulani O, Fitzgerald M, Schouten EJ, Libamba E.

Int J Tuberc Lung Dis. 2007 Apr;11(4):412-6.

PMID:
17394687
16.

Who starts? Factors associated with starting antiretroviral therapy among eligible patients in two, public HIV clinics in Lilongwe, Malawi.

Feldacker C, Johnson D, Hosseinipour M, Phiri S, Tweya H.

PLoS One. 2012;7(11):e50871. doi: 10.1371/journal.pone.0050871.

17.

Which health care facilities do adult Malawian antiretroviral therapy patients utilize during intercurrent illness?A cross sectional study.

Masangalawe C, Kandulu A, van Oosterhout JJ.

BMC Health Serv Res. 2011 Dec 21;11:345. doi: 10.1186/1472-6963-11-345.

18.

Follow-Up Visit Patterns in an Antiretroviral Therapy (ART) programme in Zomba, Malawi.

Rachlis B, Cole DC, van Lettow M, Escobar M, Muula AS, Ahmad F, Orbinski J, Chan AK.

PLoS One. 2014 Jul 17;9(7):e101875. doi: 10.1371/journal.pone.0101875.

19.

Population-level reduction in adult mortality after extension of free anti-retroviral therapy provision into rural areas in northern Malawi.

Floyd S, Molesworth A, Dube A, Banda E, Jahn A, Mwafulirwa C, Ngwira B, Branson K, Crampin AC, Zaba B, Glynn JR, French N.

PLoS One. 2010 Oct 19;5(10):e13499. doi: 10.1371/journal.pone.0013499.

20.

Antiretroviral therapy uptake and coverage in four HIV community cohort studies in sub-Saharan Africa.

Wringe A, Floyd S, Kazooba P, Mushati P, Baisley K, Urassa M, Molesworth A, Schumacher C, Todd J, Zaba B.

Trop Med Int Health. 2012 Aug;17(8):e38-48. doi: 10.1111/j.1365-3156.2011.02925.x.

Items per page

Supplemental Content

Support Center